Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.23.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Taxes  
Schedule for Deferred Tax Assets

 

 

December 31, 2021

As Previously Reported

 

 

2021

Adjustment

 

 

December 31, 2021

As Revised

 

Stock-based compensation

 

$ 3.1

 

 

$

 

 

$ 3.1

 

Patent impairment provision

 

 

0.3

 

 

 

 

 

 

0.3

 

Net operating loss carry-forwards

 

 

27.6

 

 

 

(15.9 )

 

 

11.7

 

Research and development tax credits

 

 

0.3

 

 

 

 

 

 

0.3

 

Less: valuation allowance

 

 

(31.3 )

 

 

15.9

 

 

 

(15.4 )

Total

 

$

 

 

$

 

 

$

 

 

 

December 31, 2022

 

 

December 31, 2021

As Revised

 

Stock-based compensation

 

$ 3.5

 

 

$ 3.1

 

Patent impairment provision

 

 

0.4

 

 

 

0.3

 

Net operating loss carry-forwards

 

 

13.6

 

 

 

11.7

 

Research and development expenses – capitalized for tax purposes

 

 

0.1

 

 

 

 

Research and development tax credits

 

 

0.3

 

 

 

0.3

 

Less: valuation allowance

 

 

(17.9 )

 

 

(15.4 )

Total

 

$

 

 

$

 

Summary of income taxes (benefit)

 

 

December 31, 2022

 

 

December 31, 2021

 

Tax benefit at U.S. federal statutory rates

 

$ (1.6 )

 

$ (1.7 )

Tax benefit at state statutory rates

 

 

(0.4 )

 

 

(0.2 )

Tax benefit from federal and state R&D tax credits

 

 

 

 

 

 

Other

 

 

(0.4 )

 

 

 

Increase in valuation allowance

 

 

2.4

 

 

 

1.9

 

Total provision for income tax benefit

 

$

 

 

$